Notably, published studies with LTA4H KO mice as well as reports with previously described aminopeptidase-interfering LTA4H inhibitors unanimously demonstrated a strong anti-inflammatory effect, particularly in models of neutrophil-driven sterile inflammation, such as colitis, arthritis and asthma16. Here, LTA4H is linked to colitis.